
Regeneron Pharmaceuticals Inc (1REGN)
BIT
The current 1REGN market cap is 70.8B. The company's latest EPS is USD 40.3623 and P/E is 17.92.
Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 8.78B | 16.12B | 12.26B | 13.12B | 14.2B |
Operating Income | 3.58B | 8.95B | 4.74B | 4.05B | 3.99B |
Net Income | 3.51B | 8.08B | 4.34B | 3.95B | 4.41B |
Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 17.16B | 25.43B | 29.21B | 33.08B | 37.76B |
Total Liabilities | 6.14B | 6.67B | 6.55B | 7.11B | 8.41B |
Total Equity | 11.03B | 18.77B | 22.66B | 25.97B | 29.35B |
Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | 2.62B | 7.08B | 5.01B | 4.59B | 4.42B |
Investing | -70.6M | -5.38B | -3.78B | -3.19B | -2.47B |
Financing | -1.97B | -1.01B | -1.01B | -1.79B | -2.2B |
Market Cap | 70.8B |
Price to Earnings Ratio | 17.92 |
Price to Sales Ratio | 5.57 |
Price to Cash Ratio | 31.79 |
Price to Book Ratio | 2.69 |
Dividend Yield | 0.14% |
Shares Outstanding | 109.32M |
Average Volume (1 week) | 0 |
Average Volume (1 Month) | 11 |
52 Week Change | -29.91% |
52 Week High | 1,094.50 |
52 Week Low | 647.60 |
Spread (Intraday) | 3.2 (0.46%) |
Company Name | Regeneron Pharmaceuticals Inc |
Address |
28 liberty street new york, new york 10005 |
Website | https://www.regeneron.com |
Industry | health care diversified (H) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.